Detalhe da pesquisa
1.
Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients' Outcomes?
Cancers (Basel)
; 15(3)2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765750
2.
Biological Biomarkers of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma.
Cancers (Basel)
; 15(12)2023 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370768
3.
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France.
Bull Cancer
; 110(10): 1041-1050, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659907
4.
Advanced nccRCC: what therapeutic options in 2022?
Bull Cancer
; 109(2S): 2S39-2S46, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35760469